Pan-Cancer Insights: A Study of Microbial Metabolite Receptors in Malignancy Dynamics
2024

Microbial Metabolite Receptors in Cancer

Sample size: 8500 publication 10 minutes Evidence: high

Author Information

Author(s): Dovrolis Nikolas, Spathakis Michail, Collins Alexandra R., Pandey Varun Kumar, Uddin Muhammad Ikhtear, Anderson Donald D., Kaminska Tetiana, Paspaliaris Vasilis, Kolios George, Yoshiyama Hironori, Marotta Francesco

Primary Institution: Democritus University of Thrace

Hypothesis

This study investigates the involvement of microbial metabolite receptors (MMRs) in human cells across twenty-three types of cancer.

Conclusion

The interactions between microbial metabolites and MMRs may serve as potential biomarkers for cancer diagnosis, prognosis, and therapy.

Supporting Evidence

  • Certain MMRs are consistently upregulated in various malignancies.
  • Identified significant correlations between MMR expression and cancer hallmark genes and pathways.
  • Microbial metabolites can influence cancer development and progression.

Takeaway

Bacteria in our gut can affect cancer by producing substances that interact with our cells, and this study looks at how these interactions happen in different types of cancer.

Methodology

The study analyzed transcriptomic profiles of 107 MMRs across 23 cancer types using data from cancer cell lines and human tumor samples.

Potential Biases

The reliance on existing datasets may introduce biases related to data quality and representativeness.

Limitations

The study is based entirely on in silico analyses without experimental validation.

Participant Demographics

The study analyzed data from approximately 8500 tumor samples and 740 matched controls across various cancer types.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/cancers16244178

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication